According to a recent Israeli study, a dedicated hyperbaric oxygen therapy (HBOT) protocol was more effective in reducing pain than available drugs in patients suffering from fibromyalgia following head injury.
Fibromyalgia Syndrome (FMS) is a common condition affecting about 4 million U.S. adults or about 2 percent of the adult population. It is clinically characterized by widespread chronic pain, dyscognition (fibro fog), and associated symptoms.
“Existing treatments are not good enough,”  one of the leading researchers, Dr. Jacob Ablin from the Tel Aviv Sourasky Medical Center, said in a statement. “It is a chronic disease that significantly affects the quality of life, including young people, and hyperbaric medicine meets an acute need of these patients.”…